FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler | GenomeWeb

This article has been updated to note that the Focus test was cleared by FDA two years ago for high-complexity labs.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to Focus Diagnostics' Simplexa Flu A/B & RSV Direct test, Focus and 3M announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.